share_log

Shineco, Inc. Explores Medical Aesthetic Industry by Entering into MOU with Dragon Pride Limited

Shineco, Inc. Explores Medical Aesthetic Industry by Entering into MOU with Dragon Pride Limited

新科公司與Dragon Pride Limited簽訂諒解備忘錄開拓醫療美容產業
GlobeNewswire ·  2021/10/26 21:00

BEIJING, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that it entered into a Memorandum of Understanding ("MOU") with Dr. Angus Hui, the founder and sole shareholder of Dragon Pride Limited ("Dragon Pride"), a renowned medical aesthetic service provider in Hong Kong, pursuant to which the Company has an exclusive right during a period of 90 days to negotiate the terms of an definitive agreement to acquire either 100% of the equity interest of Dragon Pride or not less than 50% of the equity interest of the Medical Aesthetic Center, subject to a definitive agreement.

北京,2021年10月26日(環球通訊社)--新科公司(“新科”或“公司”;納斯達克股票代碼:SISI),一家生產和分銷中草藥,有機農業和其他生物技術產品的公司宣佈,它與香港著名醫療美容服務提供商Dragon Pride Limited(“Dragon Pride”)的創始人和唯一股東許安格斯博士簽訂了一份諒解備忘錄(“MOU”),據此,公司有權在90天內就收購Dragon Pride 100%股權或收購Dragon Pride的100%股權的最終協議條款進行獨家談判;根據該諒解備忘錄,本公司將與香港著名醫療美容服務提供商Dragon Pride Limited(“Dragon Pride”)的創辦人及唯一股東許志剛博士訂立諒解備忘錄,就收購Dragon Pride Limited(“Dragon Pride”)的100%股權進行最終協議談判。

Dragon Pride was founded by Dr. Angus Hui in 2008. Dr. Angus Hui also runs other health brands, such as WAYOUNG, CONCENTRIC and Drd that together known as "Angus Beauty Concept". Dragon Pride provides customers with a broad range of medical aesthetic services to meet their different aesthetic and anti-aging needs. Its medical aesthetic services include: aesthetic surgery services including aesthetic surgical on the face or various parts of body, minimally-invasive aesthetic services, aesthetic injection and aesthetic dermatology services.

龍驕傲是由許志永博士於2008年創立的。許安格斯博士還經營着其他健康品牌,如WAYOUNG、SYNERRINE和DRD,這些品牌統稱為“安格斯美容概念”(Angus Beauty Concept)。龍驕傲為客户提供廣泛的醫療美容服務,以滿足他們不同的美容和抗衰老需求。其醫療美容服務包括:美容外科服務,包括面部或身體各部位的美容手術,微創美容服務,美容注射和美容皮膚科服務。

Ms. Jennifer Zhan, CEO of Shineco, commented, "We are pleased to pursue this potential acquisition, which may expand the Company's business scope if it is completed. According to International Society of Aesthetic Plastic Surgery and ChinaIRN, China has become one of the fastest-growing medical aesthetic service markets in the world, with an annual compound growth rate of more than 20%. In 2020, the market size of China's medical aesthetic industry will exceed $39 billion, and it is expected to reach $75.2 billion in 2022."

新科首席執行官詹妮弗·詹女士評價稱,“我們很高興進行這項潛在的收購,如果完成可能會擴大公司的業務範圍.根據國際美容整形外科學會和ChinaIRN的數據,中國已成為全球增長最快的醫療美容服務市場之一,年複合增長率超過20%.2020年,中國醫療美容行業的市場規模將超過390億美元,預計2022年將達到752億美元.”

Ms. Zhan continued, "In addition to founding Dragon Pride, Dr. Angus Hui has rich experience in the operation and management of medical aesthetic centers. If the acquisition is closed, with the expertise and leadership of Dr. Angus Hui, we believe Shineco will be better positioned to accomplish the goal of opening more than 10 medical aesthetic centers in China in the next three years, which we believe will generate annual net profit of no less than RMB100 million for the Company."

詹麗君接着説:“除了創立龍騰美容中心外,許安格斯博士在醫療美容中心的運營和管理方面擁有豐富的經驗。如果收購完成,在許仕仁博士的專業知識和領導下,我們相信新科將在未來三年內更好地實現在中國開設10家以上醫療美容中心的目標,我們相信這將為本公司帶來不低於1億元人民幣的年淨利潤。”

Dr. Angus Hui, Chairman of Dragon Pride said, "Dragon Pride's Angus Beauty Concept is located in Causeway Bay, Hong Kong, covering an area of 4,000 square feet. We have a team of medical professionals, consisting of doctors, nurses, therapists and beauticians. After the doctors' examination and evaluation on the constitution and skin types of customers, we will personalize the beauty treatments for customers to meet their unique needs. The cooperation with Shineco may create significant synergies and strengthen our capabilities in expansion. Our goal is to be a world-class medical beauty services company."

Dragon Pride主席許仕仁博士表示:“Dragon Pride的Angus美容概念位於香港銅鑼灣,佔地4,000平方英尺。我們擁有一支由醫生、護士、治療師和美容師組成的醫療專業團隊。在醫生對客户的體質和皮膚類型進行檢查和評估後,我們將為客户提供個性化的美容治療,以滿足他們的獨特需求。與新創的合作可能會產生顯著的協同效應,並增強我們的擴張能力。我們的目標是成為一個世界-

About Shineco, Inc.

關於新科公司

Incorporated in Delaware in August 1997 and headquartered in Beijing, China, Shineco is a holding company. Utilizing modern engineering technologies and biotechnologies, Shineco produces, among other products, Chinese herbal medicines, organic agricultural produce, and specialized textiles. For more information about Shineco, please visit http://tianyiluobuma.com.

新科公司於1997年8月在特拉華州成立,總部設在中國北京,是一家控股公司。新科公司利用現代工程技術和生物技術,生產中草藥、有機農產品和特種紡織品等產品。欲瞭解有關新科公司的更多信息,請訪問網址:http://tianyiluobuma.com.。

Forward-Looking Statements

前瞻性陳述

This press release contains information about Shineco's view of its future expectations, plans and prospects that constitute forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, the impact of the COVID-19 pandemic, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. Shineco encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. The forward-looking statements in this press release are based on current expectations and Shineco assumes no obligation to update these forward-looking statements.

本新聞稿包含有關新科公司對其未來預期、計劃和前景的看法的信息,這些信息構成了前瞻性陳述。告誡您不要過度依賴這些前瞻性陳述。實際結果可能與歷史結果或這些前瞻性陳述所表明的結果大不相同,這是多種因素的結果,這些因素包括但不限於與其籌集額外資金的能力、維持和發展業務的能力、經營業績的變化無常、保持和提升品牌的能力、開發和推出新產品和服務、被收購公司、技術和資產成功整合到產品和服務組合中、營銷和其他業務發展舉措、競爭等相關的風險和不確定因素。行業、政府的總體監管、經濟狀況、新冠肺炎疫情的影響、對關鍵人員的依賴、吸引、聘用和留住擁有滿足客户要求所需的技術技能和經驗的人員的能力,以及保護其知識產權的能力。Shineco鼓勵您在其註冊聲明和提交給美國證券交易委員會(Securities And Exchange Commission)的其他文件中審查可能影響其未來業績的其他因素。本新聞稿中的前瞻性陳述是基於當前的預期,新科公司沒有義務更新這些前瞻性陳述。.

For more information, please contact:

如需更多信息,請聯繫:

Tina Xiao
Ascent Investor Relations LLC
Phone: +1-917-609-0333
Email: tina.xiao@ascent-ir.com

蒂娜·肖上升投資者關係有限責任公司電話:+1-917-609-0333電子郵件:郵箱:tina.xiao@ascent-ir.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論